Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Xenotransplantation: Science, Ethics, and Public Policy.

Institute of Medicine (US) Committee on Xenograft Transplantation: Ethical Issues and Public Policy.

Washington (DC): National Academies Press (US); 1996.

2.

Xenograft Transplantation of the Infectious Disease Conundrum.

Allan JS.

ILAR J. 1995;37(1):37-48. No abstract available.

PMID:
11528023
3.

Ethical Aspects of Animal to Human Xenografts.

McCarthy CR.

ILAR J. 1995;37(1):3-9. No abstract available.

PMID:
11528017
4.

Liver transplantation in a managed care environment.

Evans RW.

Liver Transpl Surg. 1995 Jan;1(1):61-75; discussion 80-2. Review. No abstract available.

5.

Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance.

Starzl TE, Demetris AJ, Trucco M, Murase N, Ricordi C, Ildstad S, Ramos H, Todo S, Tzakis A, Fung JJ, et al.

Hepatology. 1993 Jun;17(6):1127-52. Review. No abstract available.

6.

Regulation of somatic-cell therapy and gene therapy by the food and drug administration.

Kessler DA, Siegel JP, Noguchi PD, Zoon KC, Feiden KL, Woodcock J.

N Engl J Med. 1993 Oct 14;329(16):1169-73. Review. No abstract available.

7.

Xenotransplant-associated zoonoses. Strategies for prevention.

Michaels MG, Simmons RL.

Transplantation. 1994 Jan;57(1):1-7. Review. No abstract available.

PMID:
8291094
8.

Brief report: infection of a laboratory worker with simian immunodeficiency virus.

Khabbaz RF, Heneine W, George JR, Parekh B, Rowe T, Woods T, Switzer WM, McClure HM, Murphey-Corb M, Folks TM.

N Engl J Med. 1994 Jan 20;330(3):172-7. No abstract available.

9.

Protection of encapsulated human islets implanted without immunosuppression in patients with type I or type II diabetes and in nondiabetic control subjects.

Scharp DW, Swanson CJ, Olack BJ, Latta PP, Hegre OD, Doherty EJ, Gentile FT, Flavin KS, Ansara MF, Lacy PE.

Diabetes. 1994 Sep;43(9):1167-70.

PMID:
8070618
10.

Immunosuppressive agents.

Kahan BD, Ghobrial R.

Surg Clin North Am. 1994 Oct;74(5):1029-54. Review.

PMID:
7940060
11.

Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells.

Kaufman CL, Colson YL, Wren SM, Watkins S, Simmons RL, Ildstad ST.

Blood. 1994 Oct 15;84(8):2436-46.

13.

Endothelial cell activation and thromboregulation during xenograft rejection.

Bach FH, Robson SC, Ferran C, Winkler H, Millan MT, Stuhlmeier KM, Vanhove B, Blakely ML, van der Werf WJ, Hofer E, et al.

Immunol Rev. 1994 Oct;141:5-30. Review. No abstract available.

PMID:
7868157
14.

Oligosaccharides and discordant xenotransplantation.

Cooper DK, Koren E, Oriol R.

Immunol Rev. 1994 Oct;141:31-58. Review.

PMID:
7868156
15.

A perspective on xenograft rejection and accommodation.

Platt JL.

Immunol Rev. 1994 Oct;141:127-49. Review.

PMID:
7868152
16.
17.

Public policy governing organ and tissue procurement in the United States. Results from the National Organ and Tissue Procurement Study.

Siminoff LA, Arnold RM, Caplan AL, Virnig BA, Seltzer DL.

Ann Intern Med. 1995 Jul 1;123(1):10-7.

PMID:
7762908
18.

The use of anencephalic neonates as organ donors. Council on Ethical and Judicial Affairs, American Medical Association.

[No authors listed]

JAMA. 1995 May 24-31;273(20):1614-8. No abstract available.

PMID:
7745776
19.

Xenotransplantation.

Kaufman CL, Gaines BA, Ildstad ST.

Annu Rev Immunol. 1995;13:339-67. Review.

PMID:
7612227
20.

High survival rates of kidney transplants from spousal and living unrelated donors.

Terasaki PI, Cecka JM, Gjertson DW, Takemoto S.

N Engl J Med. 1995 Aug 10;333(6):333-6.

Supplemental Content

Support Center